ATM Dependent DUSP6 Modulation of P53 Involved in Synergistic Targeting of MAPK and P53 Pathways With Trametinib and MDM2 Inhibitors in Cutaneous Melanoma
Cancers - Switzerland
doi 10.3390/cancers11010003
Full Text
Open PDFAbstract
Available in full text
Date
December 20, 2018
Authors
Publisher
MDPI AG